167 related articles for article (PubMed ID: 8149949)
1. Comparative pharmacokinetics of silipide and silymarin in rats.
Morazzoni P; Montalbetti A; Malandrino S; Pifferi G
Eur J Drug Metab Pharmacokinet; 1993; 18(3):289-97. PubMed ID: 8149949
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients.
Schandalik R; Gatti G; Perucca E
Arzneimittelforschung; 1992 Jul; 42(7):964-8. PubMed ID: 1329780
[TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability of Silipide, a new flavanolignan complex, in rats.
Morazzoni P; Magistretti MJ; Giachetti C; Zanolo G
Eur J Drug Metab Pharmacokinet; 1992; 17(1):39-44. PubMed ID: 1499596
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of silybin following oral administration of silipide in patients with extrahepatic biliary obstruction.
Schandalik R; Perucca E
Drugs Exp Clin Res; 1994; 20(1):37-42. PubMed ID: 7924893
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers.
Gatti G; Perucca E
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):614-7. PubMed ID: 7874377
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects.
Barzaghi N; Crema F; Gatti G; Pifferi G; Perucca E
Eur J Drug Metab Pharmacokinet; 1990; 15(4):333-8. PubMed ID: 2088770
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of a silybin-phosphatidylcholine complex in dogs.
Filburn CR; Kettenacker R; Griffin DW
J Vet Pharmacol Ther; 2007 Apr; 30(2):132-8. PubMed ID: 17348898
[TBL] [Abstract][Full Text] [Related]
8. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals.
Comoglio A; Tomasi A; Malandrino S; Poli G; Albano E
Biochem Pharmacol; 1995 Oct; 50(8):1313-6. PubMed ID: 7488251
[TBL] [Abstract][Full Text] [Related]
9. Protective activity of silipide on liver damage in rodents.
Conti M; Malandrino S; Magistretti MJ
Jpn J Pharmacol; 1992 Dec; 60(4):315-21. PubMed ID: 1287266
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.
Wen Z; Dumas TE; Schrieber SJ; Hawke RL; Fried MW; Smith PC
Drug Metab Dispos; 2008 Jan; 36(1):65-72. PubMed ID: 17913795
[TBL] [Abstract][Full Text] [Related]
11. Development of a HPLC-UV assay for silybin-phosphatidylcholine complex (silybinin capsules) and its pharmacokinetic study in healthy male Chinese volunteers.
Li W; Gao J; Zhao HZ; Liu CX
Eur J Drug Metab Pharmacokinet; 2006; 31(4):265-70. PubMed ID: 17315537
[TBL] [Abstract][Full Text] [Related]
12. Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer.
Gallo D; Giacomelli S; Ferlini C; Raspaglio G; Apollonio P; Prislei S; Riva A; Morazzoni P; Bombardelli E; Scambia G
Eur J Cancer; 2003 Nov; 39(16):2403-10. PubMed ID: 14556934
[TBL] [Abstract][Full Text] [Related]
13. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study.
Zhu HJ; Brinda BJ; Chavin KD; Bernstein HJ; Patrick KS; Markowitz JS
Drug Metab Dispos; 2013 Sep; 41(9):1679-85. PubMed ID: 23835761
[TBL] [Abstract][Full Text] [Related]
14. Determination of active component in silymarin by RP-LC and LC/MS.
Ding T; Tian S; Zhang Z; Gu D; Chen Y; Shi Y; Sun Z
J Pharm Biomed Anal; 2001 Aug; 26(1):155-61. PubMed ID: 11451653
[TBL] [Abstract][Full Text] [Related]
15. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).
Miranda SR; Lee JK; Brouwer KL; Wen Z; Smith PC; Hawke RL
Drug Metab Dispos; 2008 Nov; 36(11):2219-26. PubMed ID: 18687803
[TBL] [Abstract][Full Text] [Related]
16. Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.
Li WY; Yu G; Hogan RM; Mohandas R; Frye RF; Gumpricht E; Markowitz JS
Clin Ther; 2018 Jan; 40(1):103-113.e1. PubMed ID: 29273470
[TBL] [Abstract][Full Text] [Related]
17. Studies on the antioxidant and free radical scavenging properties of IdB 1016 a new flavanolignan complex.
Comoglio A; Leonarduzzi G; Carini R; Busolin D; Basaga H; Albano E; Tomasi A; Poli G; Morazzoni P; Magistretti MJ
Free Radic Res Commun; 1990; 11(1-3):109-15. PubMed ID: 2074043
[TBL] [Abstract][Full Text] [Related]
18. Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.
Méndez-Sánchez N; Dibildox-Martinez M; Sosa-Noguera J; Sánchez-Medal R; Flores-Murrieta FJ
BMC Pharmacol Toxicol; 2019 Jan; 20(1):5. PubMed ID: 30635055
[TBL] [Abstract][Full Text] [Related]
19. A new drug nanocrystal self-stabilized Pickering emulsion for oral delivery of silybin.
Yi T; Liu C; Zhang J; Wang F; Wang J; Zhang J
Eur J Pharm Sci; 2017 Jan; 96():420-427. PubMed ID: 27575878
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interaction between oltipraz and silymarin in rats.
Kang MK; Bae SK; Kim JW; Lee MG
J Pharm Pharm Sci; 2009; 12(1):1-16. PubMed ID: 19470289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
